Probe Set Gene Accession Fold Change Supplemental Table 1

Total Page:16

File Type:pdf, Size:1020Kb

Probe Set Gene Accession Fold Change Supplemental Table 1 Supplemental Table 1. dCHIP Analysis of Gene Expression Changes in Ad-FHIT- transduced H1299 cells compared to those in Ad-EV-transduced cells. Probe set Gene Accession Fold Change 212352_s_at transmembrane trafficking protein BE780075 -2.801 203939_at 5' nucleotidase (CD73) NM_002526 -2.562 201812_s_at 6.2 kd protein NM_019059 -2.118 208736_at actin related protein 2/3 complex, subunit 3 (21 kD) AF004561 -2.352 213214_x_at actin, gamma 1 AW190090 -2.392 212363_x_at actin, gamma 1 AU145192 -2.373 221607_x_at actin, gamma 1 BC001920 -2.344 211983_x_at actin, gamma 1 BE741683 -2.266 201550_x_at actin, gamma 1 NM_001614 -2.173 211620_x_at acute myeloid leukemia associated protein (AML1EAP) L21756 -2.161 213892_s_at adenine phosphoribosyltransferase AA927724 -2.201 200011_s_at ADP-ribosylation factor 3 NM_001659 -2.164 211935_at ADP-ribosylation factor-like 6 interacting protein D31885 -2.173 211986_at AHNAK nucleoprotein (desmoyokin) BG287862 -2.363 202740_at aminoacylase 1 NM_000666 -2.108 208704_x_at amyloid beta (A4) precursor-like protein 2 BC000373 -2.544 208248_x_at amyloid beta (A4) precursor-like protein 2 NM_001642 -2.328 208703_s_at amyloid beta (A4) precursor-like protein 2 BG427393 -2.206 210027_s_at APEX nuclease (multifunctional DNA repair enzyme) M80261 -2.327 209135_at aspartate beta-hydroxylase AF289489 -2.263 207335_x_at ATP synthase, H+ transporting, mitochondrial F0 compl NM_007100 -2.385 217801_at ATP synthase, H+ transporting, mitochondrial F1 compl NM_006886 -2.112 200818_at ATP synthase, H+ transporting, mitochondrial F1 compl NM_001697 -2.128 216383_at ATP-binding cassette, sub-family D (ALD), member 1 U52111 -3.114 200921_s_at B-cell translocation gene 1, anti-proliferative NM_001731 -2.229 201848_s_at BCL2/adenovirus E1B 19kD interacting protein 3 U15174 -2.761 201849_at BCL2/adenovirus E1B 19kD interacting protein 3 NM_004052 -2.632 201828_x_at CAAX box 1 NM_003928 -2.235 214665_s_at calcium binding protein P22 AK000095 -2.317 200653_s_at calmodulin 1 (phosphorylase kinase, delta) M27319 -2.255 216194_s_at calpain, small subunit 1 AD001527 -2.156 215733_x_at cancer/testis antigen 2 AJ012833 -2.367 202122_s_at cargo selection protein (mannose 6 phosphate receptor NM_005817 -2.654 210844_x_at catenin (cadherin-associated protein), alpha 1 (102kD) D14705 -2.148 212097_at caveolin 1, caveolae protein, 22kD AU147399 -3.322 204490_s_at CD44 antigen (homing function and Indian blood group M24915 -2.481 212014_x_at CD44 antigen (homing function and Indian blood group AI493245 -2.251 209835_x_at CD44 antigen (homing function and Indian blood group BC004372 -2.230 211974_x_at CD59 antigen p18-20 AL513759 -2.552 201005_at CD9 antigen (p24) NM_001769 -2.329 220864_s_at cell death-regulatory protein GRIM19 NM_015965 -2.163 217122_s_at cell division cycle 2-like 2 AL031282 -2.927 209143_s_at chloride channel, nucleotide-sensitive, 1A AF005422 -2.219 208659_at chloride intracellular channel 1 AF034607 -2.143 201560_at chloride intracellular channel 4 NM_013943 -2.407 208294_x_at chorionic somatomammotropin hormone-like 1 NM_022578 -2.227 204050_s_at clathrin, light polypeptide (Lca) NM_001833 -2.212 201358_s_at coatomer protein complex, subunit beta NM_016451 -2.311 200810_s_at cold inducible RNA binding protein NM_001280 -2.279 200811_at cold inducible RNA binding protein NM_001280 -2.254 216570_x_at Consensus includes gb:AL096829 /DEF=Human DNA sAL096829 -2.459 221483_s_at cyclic AMP phosphoprotein, 19 kD AF084555 -2.348 202705_at cyclin B2 NM_004701 -2.137 208796_s_at cyclin G1 BC000196 -2.694 217491_x_at cytochrome c oxidase subunit VIIc pseudogene 1 AF042165 -2.180 200794_x_at DAZ associated protein 2 NM_014764 -2.720 210137_s_at dCMP deaminase BC001286 -2.432 202231_at dendritic cell protein NM_006360 -2.234 214247_s_at dickkopf homolog 3 (Xenopus laevis) AU148057 -2.171 201412_at DKFZP564C1940 protein NM_014045 -2.437 209177_at DKFZP564J0123 protein BC002873 -2.124 208891_at dual specificity phosphatase 6 BC003143 -2.595 211684_s_at dynein, cytoplasmic, intermediate polypeptide 2 AF250307 -2.115 205596_s_at E3 ubiquitin ligase SMURF2 AY014180 -2.430 217719_at eIEF associated protein HSPC021 NM_016091 -2.475 209058_at endothelial differentiation-related factor 1 AB002282 -2.302 37796_at erythropoietin AF053356 2.718 215096_s_at esterase Dformylglutathione hydrolase AU145746 -2.367 211234_x_at estrogen receptor 1 AF258449 -4.496 204540_at eukaryotic translation elongation factor 1 alpha 2 NM_001958 -2.098 200094_s_at eukaryotic translation elongation factor 2 AI004246 -2.588 204102_s_at eukaryotic translation elongation factor 2 NM_001961 -2.219 208726_s_at eukaryotic translation initiation factor 2, subunit 2 (beta, BC000461 -2.159 200023_s_at eukaryotic translation initiation factor 3, subunit 5 (epsiloNM_003754 -2.305 208697_s_at eukaryotic translation initiation factor 3, subunit 6 (48kD BC000734 -2.315 200912_s_at eukaryotic translation initiation factor 4A, isoform 2 NM_001967 -2.358 203719_at excision repair cross-complementing rodent repair defic NM_001983 -2.252 203720_s_at excision repair cross-complementing rodent repair defic NM_001983 -2.136 208775_at exportin 1 (CRM1 homolog, yeast) D89729 -2.373 208647_at farnesyl-diphosphate farnesyltransferase 1 AA872727 -2.553 212320_at FK506 binding protein 1A (12kD) BC001002 -2.690 206492_at fragile histidine triad gene NM_002012 6.959 201637_s_at fragile X mental retardation, autosomal homolog 1 NM_005087 -2.460 208235_x_at G antigen 7 NM_021123 -2.141 218205_s_at G protein-coupled receptor kinase 7 NM_017572 -3.223 210891_s_at general transcription factor II, i AF035737 -2.416 217814_at GK001 protein NM_020198 -2.567 217807_s_at glioma tumor suppressor candidate region gene 2 NM_015710 -3.150 209398_at H1 histone family, member 2 BC002649 -2.224 215071_s_at H1 histone family, member 4 AL353759 -2.335 200080_s_at H3 histone, family 3A AI955655 -2.133 201841_s_at heat shock 27kD protein 1 NM_001540 -2.385 208687_x_at heat shock 70kD protein 8 AF352832 -2.823 221891_x_at heat shock 70kD protein 8 AA704004 -2.739 210338_s_at heat shock 70kD protein 8 AB034951 -2.276 200064_at heat shock 90kD protein 1, beta AF275719 -2.277 201132_at heterogeneous nuclear ribonucleoprotein H2 (H') NM_019597 -2.413 202887_s_at HIF-1 responsive RTP801 NM_019058 -2.440 208025_s_at high-mobility group (nonhistone chromosomal) protein isNM_003483 -2.995 206074_s_at high-mobility group (nonhistone chromosomal) protein isNM_002131 -2.078 212552_at hippocalcin-like 1 BE617588 -2.194 218092_s_at HIV-1 Rev binding protein NM_004504 -3.984 208788_at homolog of yeast long chain polyunsaturated fatty acid eAL136939 -2.360 217917_s_at HSPC162 protein NM_014183 -2.087 211598_x_at Human PACAP type-3VIP type-2 receptor mRNA U18810 -2.104 212994_at hypothetical protein LOC57187 BE543527 3.970 220134_x_at hypothetical protein FLJ10647 NM_018166 -2.301 219126_at hypothetical protein FLJ10975 NM_018288 3.282 220774_at hypothetical protein FLJ20071 NM_017653 -2.288 220600_at hypothetical protein FLJ20211 NM_017713 2.925 212297_at hypothetical protein FLJ20986 BF218804 -2.576 202371_at hypothetical protein FLJ21174 NM_024863 -2.209 221844_x_at hypothetical protein FLJ22059 AV756161 -2.231 209679_s_at hypothetical protein from clone 643 BC003379 -2.353 218097_s_at hypothetical protein MGC2491 NM_024040 -2.270 210933_s_at hypothetical protein MGC4655 BC004908 -2.399 216271_x_at ilvB (bacterial acetolactate synthase)-like AC004794 5.654 201631_s_at immediate early response 3 NM_003897 -2.368 202105_at immunoglobulin (CD79A) binding protein 1 NM_001551 -2.371 201474_s_at integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLANM_002204 -2.488 201656_at integrin, alpha 6 NM_000210 -2.160 200791_s_at IQ motif containing GTPase activating protein 1 NM_003870 -2.284 212074_at KIAA0810 protein BE972774 -2.392 202304_at KIAA0970 protein NM_014923 -2.374 201105_at lectin, galactoside-binding, soluble, 1 (galectin 1) NM_002305 -2.491 208771_s_at leukotriene A4 hydrolase J02959 -2.419 202822_at LIM domain-containing preferred translocation partner inBF221852 -2.229 214110_s_at lymphocyte-specific protein 1 BF195104 -2.330 217871_s_at macrophage migration inhibitory factor (glycosylation-inhNM_002415 -2.119 209329_x_at mannan-binding lectin serine protease 1 (C4/C2 activati BC000587 -2.454 214254_at melanoma antigen, family A, 4 AW438674 -2.469 209014_at melanoma antigen, family D, 1 AF217963 -2.293 212859_x_at metallothionein 1E (functional) BF217861 -2.163 204745_x_at metallothionein 1G NM_005950 -2.180 211456_x_at metallothionein 1H AF333388 -2.839 206461_x_at metallothionein 1H NM_005951 -2.189 204326_x_at metallothionein 1L NM_002450 -2.235 208581_x_at metallothionein 1X NM_005952 -2.158 212185_x_at metallothionein 2A NM_005953 -2.218 212085_at mitochondrial carrier; adenine nucleotide translocator, mAA916851 -2.313 220526_s_at mitochondrial ribosomal protein L20 NM_017971 -2.528 218270_at mitochondrial ribosomal protein L24 NM_024540 -2.201 217408_at mitochondrial ribosomal protein S18B AL050361 -2.246 217942_at mitochondrial ribosomal protein S35 NM_021821 -2.188 200797_s_at myeloid cell leukemia sequence 1 (BCL2-related) AI275690 -3.358 205144_at myosin, light polypeptide 5, regulatory L03785 8.685 202298_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplexNM_004541 -2.152 218160_at NADH dehydrogenase (ubiquinone) 1 alpha subcomplexNM_014222 -2.296 203478_at NADH dehydrogenase (ubiquinone) 1, subcomplex unknNM_002494 -2.190 209303_at NADH dehydrogenase (ubiquinone) Fe-S protein 4 (18kBC005270 -2.193
Recommended publications
  • ASPA Gene Aspartoacylase
    ASPA gene aspartoacylase Normal Function The ASPA gene provides instructions for making an enzyme called aspartoacylase. In the brain, this enzyme breaks down a compound called N-acetyl-L-aspartic acid (NAA) into aspartic acid (an amino acid that is a building block of many proteins) and another molecule called acetic acid. The production and breakdown of NAA appears to be critical for maintaining the brain's white matter, which consists of nerve fibers surrounded by a myelin sheath. The myelin sheath is the covering that protects nerve fibers and promotes the efficient transmission of nerve impulses. The precise function of NAA is unclear. Researchers had suspected that it played a role in the production of the myelin sheath, but recent studies suggest that NAA does not have this function. The enzyme may instead be involved in the transport of water molecules out of nerve cells (neurons). Health Conditions Related to Genetic Changes Canavan disease More than 80 mutations in the ASPA gene are known to cause Canavan disease, which is a rare inherited disorder that affects brain development. Researchers have described two major forms of this condition: neonatal/infantile Canavan disease, which is the most common and most severe form, and mild/juvenile Canavan disease. The ASPA gene mutations that cause the neonatal/infantile form severely impair the activity of aspartoacylase, preventing the breakdown of NAA and allowing this substance to build up to high levels in the brain. The mutations that cause the mild/juvenile form have milder effects on the enzyme's activity, leading to less accumulation of NAA.
    [Show full text]
  • Global Histone Modification Fingerprinting in Human Cells Using
    OPEN Citation: Cell Death Discovery (2017) 3, 16077; doi:10.1038/cddiscovery.2016.77 Official journal of the Cell Death Differentiation Association www.nature.com/cddiscovery ARTICLE Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array Marina Partolina1,HazelCThoms1, Kenneth G MacLeod2, Giovanny Rodriguez-Blanco1,MatthewNClarke1, Anuroop V Venkatasubramani1,3, Rima Beesoo4, Vladimir Larionov5, Vidushi S Neergheen-Bhujun4, Bryan Serrels2, Hiroshi Kimura6, Neil O Carragher2 and Alexander Kagansky1,7 The balance between acetylation and deacetylation of histone proteins plays a critical role in the regulation of genomic functions. Aberrations in global levels of histone modifications are linked to carcinogenesis and are currently the focus of intense scrutiny and translational research investments to develop new therapies, which can modify complex disease pathophysiology through epigenetic control. However, despite significant progress in our understanding of the molecular mechanisms of epigenetic machinery in various genomic contexts and cell types, the links between epigenetic modifications and cellular phenotypes are far from being clear. For example, enzymes controlling histone modifications utilize key cellular metabolites associated with intra- and extracellular feedback loops, adding a further layer of complexity to this process. Meanwhile, it has become increasingly evident that new assay technologies which provide robust and precise measurement of global histone modifications are required,
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors S
    Authors: Pallavi Subhraveti Ron Caspi Quang Ong Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000725805Cyc: Streptomyces xanthophaeus Cellular Overview Connections between pathways are omitted for legibility.
    [Show full text]
  • Identification of Proteins Differentially Expressed in the Conventional Renal Cell Carcinoma by Proteomic Analysis
    J Korean Med Sci 2005; 20: 450-5 Copyright � The Korean Academy ISSN 1011-8934 of Medical Sciences Identification of Proteins Differentially Expressed in the Conventional Renal Cell Carcinoma by Proteomic Analysis Renal cell carcinoma (RCC) is one of the most malignant tumors in urology, and Jeong Seok Hwa, Hyo Jin Park*, due to its insidious onset patients frequently have advanced disease at the time of Jae Hun Jung, Sung Chul Kam, clinical presentation. Thus, early detection is crucial in management of RCC. To Hyung Chul Park, Choong Won Kim*, identify tumor specific proteins of RCC, we employed proteomic analysis. We pre- Kee Ryeon Kang*, Jea Seog Hyun, Ky Hyun Chung pared proteins from conventional RCC and the corresponding normal kidney tis- sues from seven patients with conventional RCC. The expression of proteins was Department of Urology and Biochemistry*, College of determined by silver stain after two-dimensional polyacrylamide gel electrophore- Medicine and Institute of Health Science, sis (2D-PAGE). The overall protein expression patterns in the RCC and the normal Gyeongsang National University, Jinju, Korea kidney tissues were quite similar except some areas. Of 66 differentially expressed Received : 29 December 2004 protein spots (p<0.05 by Student t-test), 8 different proteins from 11 spots were Accepted : 13 January 2005 identified by MALDI-TOF-MS. The expression of the following proteins was repress- ed (p<0.05); aminoacylase-1, enoyl-CoA hydratase, aldehyde reductase, tropo- Address for correspondence myosin -4 chain, agmatinase and ketohexokinase. Two proteins, vimentin and -1 Jeong Seok Hwa, M.D. Department of Urology, College of Medicine, antitrypsin precursor, were dominantly expressed in RCC (p<0.05).
    [Show full text]
  • CUMMINGS-DISSERTATION.Pdf (4.094Mb)
    D-AMINOACYLASES AND DIPEPTIDASES WITHIN THE AMIDOHYDROLASE SUPERFAMILY: RELATIONSHIP BETWEEN ENZYME STRUCTURE AND SUBSTRATE SPECIFICITY A Dissertation by JENNIFER ANN CUMMINGS Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY December 2010 Major Subject: Chemistry D-AMINOACYLASES AND DIPEPTIDASES WITHIN THE AMIDOHYDROLASE SUPERFAMILY: RELATIONSHIP BETWEEN ENZYME STRUCTURE AND SUBSTRATE SPECIFICITY A Dissertation by JENNIFER ANN CUMMINGS Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Approved by: Chair of Committee, Frank Raushel Committee Members, Paul Lindahl David Barondeau Gregory Reinhart Head of Department, David Russell December 2010 Major Subject: Chemistry iii ABSTRACT D-Aminoacylases and Dipeptidases within the Amidohydrolase Superfamily: Relationship Between Enzyme Structure and Substrate Specificity. (December 2010) Jennifer Ann Cummings, B.S., Southern Oregon University; M.S., Texas A&M University Chair of Advisory Committee: Dr. Frank Raushel Approximately one third of the genes for the completely sequenced bacterial genomes have an unknown, uncertain, or incorrect functional annotation. Approximately 11,000 putative proteins identified from the fully-sequenced microbial genomes are members of the catalytically diverse Amidohydrolase Superfamily. Members of the Amidohydrolase Superfamily separate into 24 Clusters of Orthologous Groups (cogs). Cog3653 includes proteins annotated as N-acyl-D-amino acid deacetylases (DAAs), and proteins within cog2355 are homologues to the human renal dipeptidase. The substrate profiles of three DAAs (Bb3285, Gox1177 and Sco4986) and six microbial dipeptidase (Sco3058, Gox2272, Cc2746, LmoDP, Rsp0802 and Bh2271) were examined with N-acyl-L-, N-acyl-D-, L-Xaa-L-Xaa, L-Xaa-D-Xaa and D-Xaa-L-Xaa substrate libraries.
    [Show full text]
  • WO2019226953A1.Pdf
    ) ( 2 (51) International Patent Classification: Street, Brookline, MA 02446 (US). WILSON, Christo¬ C12N 9/22 (2006.01) pher, Gerard; 696 Main Street, Apartment 311, Waltham, MA 0245 1(US). DOMAN, Jordan, Leigh; 25 Avon Street, (21) International Application Number: Somverville, MA 02143 (US). PCT/US20 19/033 848 (74) Agent: HEBERT, Alan, M. et al. ;Wolf, Greenfield, Sacks, (22) International Filing Date: P.C., 600 Atlanitc Avenue, Boston, MA 02210-2206 (US). 23 May 2019 (23.05.2019) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection av ailable) . AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (30) Priority Data: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 62/675,726 23 May 2018 (23.05.2018) US HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, 62/677,658 29 May 2018 (29.05.2018) US KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (71) Applicants: THE BROAD INSTITUTE, INC. [US/US]; MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 415 Main Street, Cambridge, MA 02142 (US). PRESI¬ OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, DENT AND FELLOWS OF HARVARD COLLEGE SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, [US/US]; 17 Quincy Street, Cambridge, MA 02138 (US).
    [Show full text]
  • Inhibition of N-Acetylglutamate Synthase by Various Monocarboxylic and Dicarboxylic Short-Chain Coenzyme a Esters and the Production of Alternative Glutamate Esters☆
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1842 (2014) 2510–2516 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbadis Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters☆ M. Dercksen a,b,⁎, L. IJlst a, M. Duran a, L.J. Mienie b, A. van Cruchten a, F.H. van der Westhuizen b, R.J.A. Wanders a a Laboratory Genetic Metabolic Diseases, Departments of Pediatrics and Clinical Chemistry, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands b Centre for Human Metabonomics, North-West University (Potchefstroom Campus), Hoffman street 11, Potchefstroom, South Africa, 2520 article info abstract Article history: Hyperammonemia is a frequent finding in various organic acidemias. One possible mechanism involves the Received 11 December 2012 inhibition of the enzyme N-acetylglutamate synthase (NAGS), by short-chain acyl-CoAs which accumulate due Received in revised form 9 April 2013 to defective catabolism of amino acids and/or fatty acids in the cell. The aim of this study was to investigate the Accepted 29 April 2013 effect of various acyl-CoAs on the activity of NAGS in conjunction with the formation of glutamate esters. NAGS Available online 2 May 2013 activity was measured in vitro using a sensitive enzyme assay with ultraperformance liquid chromatography– – Keywords: tandem mass spectrometry (UPLC MS/MS) product analysis. Propionyl-CoA and butyryl-CoA proved to be the N-acetylglutamate synthase most powerful inhibitors of N-acetylglutamate (NAG) formation.
    [Show full text]
  • N-Acetylglutamate Content in Liver and Gut of Normal and Fasted Mice, Normal Human Livers, and Livers of Individuals with Carbam
    003 I -3998/90/2704-0408$02.00/0 PEDIATRIC RESEARCH Vol. 27, No. 4, 1990 Copyright O 1990 International Pediatric Research Foundation, Inc Printed in U.S. A. N-Acetylglutamate Content in Liver and Gut of Normal and Fasted Mice, Normal Human Livers, and Livers of Individuals with Carbamyl Phosphate Synthetase or Ornithine Transcarbamylase Deficiency MENDEL TUCHMAN AND ROBERT A. HOLZKNECHT Division ofMetabolism, Depurtmmt.~ofPediatrics and Laboratory Medicine and Pulhology, Universifyu/ Minnesota, Minneapolis, Minnesota 55455 ABSTRACT. N-acetylglutamate (NAG) content was CPS I, carbamyl phosphate synthetase I measured in homogenates of liver and small intestine ob- OTC, ornithine transcarbamylase tained from normal and 24-h starved syngeneic mice. Sub- GC-MS, gas chromatography-mass spectrometry sequently, NAG was determined in normal, and in car- MSD, mass selective detector bamyl phosphate synthetase I and ornithine transcarbam- SIM, selected ion monitoring ylase enzyme-deficient human liver tissue homogenates. TMS, trimethylsilyl The method used in this study, which is direct and highly specific, used anion exchange extraction, gas chromato- graphic separation, and mass spectrometric detection and quantitation. Hepatic NAG content in the fed animals was In 1953, Grisolia and Cohen (1) discovered that a derivative 94.8 + 19.8 nmoljg tissue or 602.5 + 168.4 nmol/g protein n of L-glutamic acid enhanced the biosynthesis of L-citrulline by (mean + SD, = 5), whereas it was much lower in the preparation of mammalian liver. This naturally occumng com- fasted mice (49.4 + 13.0 nmol/g tissue or 330.1 + 113.9 n pound was isolated and identified as NAG, which is the cofactor nmol/g protein, mean + SD, = 5).
    [Show full text]
  • Global Histone Modification Fingerprinting in Human Cells Using Epigenetic Reverse Phase Protein Array
    Edinburgh Research Explorer Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array Citation for published version: Partolina, M, Thoms, HC, Macleod, KG, Rodriguez-blanco, G, Clarke, MN, Venkatasubramani, AV, Beesoo, R, Larionov, V, Neergheen-bhujun, VS, Serrels, B, Kimura, H, Carragher, NO & Kagansky, A 2017, 'Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array', Cell Death Discovery, vol. 3, pp. 16077. https://doi.org/10.1038/cddiscovery.2016.77 Digital Object Identifier (DOI): 10.1038/cddiscovery.2016.77 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Cell Death Discovery Publisher Rights Statement: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation.
    [Show full text]
  • Biochemical and Proteomic Profiling of Maize Endosperm Texture and Protein Quality Kyla J
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Theses, Dissertations, and Student Research in Agronomy and Horticulture Department Agronomy and Horticulture 7-2015 Biochemical and Proteomic Profiling of Maize Endosperm Texture and Protein Quality Kyla J. Morton University of Nebraska-Lincoln Follow this and additional works at: http://digitalcommons.unl.edu/agronhortdiss Part of the Agricultural Science Commons, Agronomy and Crop Sciences Commons, Plant Biology Commons, and the Plant Breeding and Genetics Commons Morton, Kyla J., "Biochemical and Proteomic Profiling of Maize Endosperm Texture and Protein Quality" (2015). Theses, Dissertations, and Student Research in Agronomy and Horticulture. 88. http://digitalcommons.unl.edu/agronhortdiss/88 This Article is brought to you for free and open access by the Agronomy and Horticulture Department at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Theses, Dissertations, and Student Research in Agronomy and Horticulture by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. BIOCHEMICAL AND PROTEOMIC PROFILING OF MAIZE ENDOSPERM TEXTURE AND PROTEIN QUALITY by Kyla J. Morton A DISSERTATION Presented to the Faculty of The Graduate College at the University of Nebraska In Partial Fulfillment of Requirements For the Degree of Doctor of Philosophy Major: Agronomy and Horticulture (Plant Breeding and Genetics) Under the Supervision of Professor David R. Holding Lincoln, Nebraska July, 2015 BIOCHEMICAL AND PROTEOMIC ANALYSIS OF MAIZE ENDOSPERM KERNEL TEXTURE AND PROTEIN QUALITY Kyla J. Morton, Ph.D. University of Nebraska, 2015 Advisor: David R. Holding The research described herein, focuses on the biochemical and proteomic analysis of the maize endosperm and what influences kernel texture.
    [Show full text]
  • PHARMACOLOGY REVIEW(S) Comments on N 22-562 Carbaglu Carglumic Acid from Abby Jacobs, AD Date: 3/15/10
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 22-562 PHARMACOLOGY REVIEW(S) Comments on N 22-562 Carbaglu carglumic acid From Abby Jacobs, AD Date: 3/15/10 1. I concur that there are no pharm/tox issues with approval and the labeling of pharm/tox portions is acceptable, with the changes suggested by the reviewer. 2. I do not concur with the postmarketing requests a. There is no need for a chronic study in nonrodents in addition to the rodent chronic study -The number of animals per group will be small -There are human data sufficient for approval. -The animals tested will not have the condition of hyperammonemia, and thus adverse effects observed at high doses may not be relevant to the patient population -the drug is lifesaving - the number of persons having this condition is rather small b. There is no need for a carcinogenicity study The animals tested will not have the condition of hyperammonemia, and thus adverse effects observed at high doses may not be relevant to the patient population -the drug is lifesaving and - the number of persons having this condition is rather small Application Submission Type/Number Type/Number Submitter Name Product Name -------------------- -------------------- -------------------- ------------------------------------------ NDA-22562 ORIG-1 ORPHAN EUROPE CARBAGLU (CARGLUMIC ACID) --------------------------------------------------------------------------------------------------------- This is a representation of an electronic record that was signed electronically and this page is the manifestation of the electronic signature. --------------------------------------------------------------------------------------------------------- /s/ ---------------------------------------------------- ABIGAIL ABBY C C JACOBS 03/15/2010 MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH FROM: David B.
    [Show full text]
  • The Use of Immobilized Enzymes in the Food Industry: a Review
    C R C Critical Reviews in Food Science and Nutrition ISSN: 0099-0248 (Print) (Online) Journal homepage: http://www.tandfonline.com/loi/bfsn19 The use of immobilized enzymes in the food industry: A review Arun Kilara , Khem M. Shahani & Triveni P. Shukla To cite this article: Arun Kilara , Khem M. Shahani & Triveni P. Shukla (1979) The use of immobilized enzymes in the food industry: A review, C R C Critical Reviews in Food Science and Nutrition, 12:2, 161-198, DOI: 10.1080/10408397909527276 To link to this article: https://doi.org/10.1080/10408397909527276 Published online: 29 Sep 2009. Submit your article to this journal Article views: 73 View related articles Citing articles: 24 View citing articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=bfsn19 Download by: [Texas A&M University Libraries] Date: 09 January 2018, At: 11:05 December 1979 161 THE USE OF IMMOBILIZED ENZYMES IN THE FOOD INDUSTRY: A REVIEW* Authors: ArunKilara** Khem M. Shahani Department of Food Science and Technology University of Nebraska Lincoln, Nebraska Referee: Triveni P. Shukla Krause Milling Company Milwaukee, Wisconsin INTRODUCTION Enzymes are organic substances produced by living cells which catalyze physiologi- cally significant reactions. Enzymes often are defined as biocatalysts, and they possess greater catalytic activity than chemical catalysts. All known enzymes are protein in nature and are generally colloidal, thermolabile, have relatively high molecular weights, exhibit high degrees of stereochemical and substrate specificities, and can usu- ally be isolated from the living cell. There are a wide variety of enzymes which contrib- ute, in part, to the biological diversity observed in nature.
    [Show full text]